Celcuity (CELC) Reports Q3 Loss of $0.15/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Celcuity (CELC) Reports Q3 Loss of $0.15/Share

Celcuity Reports Third Quarter 2018 Financial Results

November 13, 2018 4:00 PM EST

MINNEAPOLIS--(BUSINESS WIRE)-- Celcuity Inc. (Nasdaq: CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, announced financial results for the third quarter ended September 30, 2018.

Unless otherwise stated, all comparisons are for the third quarter ended September 30, 2018, compared to the third quarter ended September 30, 2017.

Celcuity reported a net loss of $1.9 million, or $0.18 per share, for the third quarter of 2018, compared to a net loss of $1.8 million, or $0.26 per share, for the... More